M. Traoré
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
M. Traoré has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
A. La Pean
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USA
1 shared publication- Alexander Vortmeyer
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
1 shared publication B. Niaré
Department of Neurosciences, University of Bamako, Bamako, Mali
1 shared publicationBagayoko T B
Center Fana Reference Health Center, Bamako, Mali
1 shared publicationBah A
1 shared publicationDiawara Y
Center Fana Reference Health Center, Bamako, Mali
1 shared publication
Latest Publications
- Open Access
- 18 May 2023
- Published by SASPR Edu International Pvt. Ltd in Saudi Journal of Medicine
- Vol. 8 (05) , 269-275
Epidemiological and Clinical Study of Road Accidents in the CS Réf of Fana
- 18 May 2023
- Published by SASPR Edu International Pvt. Ltd in Saudi Journal of Medicine
- Vol. 8 (05) , 269-275
Open AccessEpidemiological and Clinical Study of Road Accidents in the CS Réf of Fana
- Open Access
- 26 March 2009
- Published by Springer Nature in neurogenetics
- Vol. 10 (4) , 319-323
Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease
We studied a Malian family with parental consanguinity and two of eight siblings affected with late-childhood-onset progressive myoclonus epilepsy and cognitive decline, consistent with the diagnosis of Lafora disease. Genetic analysis showed a novel homozygous single-nucleotide variant in the NHLRC1 gene, c.560A>C, producing the missense change H187P. The changed amino acid is highly conserved, and the mutation impairs malin's ability to degrade laforin in vitro. Pathological evaluation showed manifestations of Lafora disease in the entire brain, with particularly severe involvement of the pallidum, thalamus, and cerebellum. Our findings document Lafora disease with severe manifestations in the West African population.
- 26 March 2009
- Published by Springer Nature in neurogenetics
- Vol. 10 (4) , 319-323
Open AccessNovel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease
We studied a Malian family with parental consanguinity and two of eight siblings affected with late-childhood-onset progressive myoclonus epilepsy and cognitive decline, consistent with the diagnosis of Lafora disease. Genetic analysis showed a novel homozygous single-nucleotide variant in the NHLRC1 gene, c.560A>C, producing the missense change H187P. The changed amino acid is highly conserved, and the mutation impairs malin's ability to degrade laforin in vitro. Pathological evaluation showed manifestations of Lafora disease in the entire brain, with particularly severe involvement of the pallidum, thalamus, and cerebellum. Our findings document Lafora disease with severe manifestations in the West African population.